The Role of S-Nitrosylation and S-Glutathionylation of Protein Disulphide Isomerase in Protein Misfolding and Neurodegeneration

• Published in: International Journal of Cell Biology Vol. 2013; no. 2013; pp. 518 - 532
• Main Authors: Halloran, M., Parakh, S., Atkin, Julie D.
• Format: Journal Article
• Language: English
• Published: Cairo, Egypt Hindawi Limiteds 2013; Hindawi Puplishing Corporation; Hindawi Publishing Corporation; Hindawi Limited
• Subjects: Amyotrophic lateral sclerosis; Antioxidants; Cell adhesion & migration; Chaperones; Creutzfeldt-Jakob disease; Degeneration; Deoxyribonucleic acid; DNA; Enzymes; Free radicals; Genes; Health aspects; Homeostasis; Isomerases; Mutation; Nervous system; Neurodegeneration; Neurological research; Oxidative stress; Pathogenesis; Protein folding; Protein research; Proteins; Review; Australia
• ISSN: 1687-8876; 1687-8884
• DOI: 10.1155/2013/797914

Neurodegenerative diseases involve the progressive loss of neurons, and a pathological hallmark is the presence of abnormal inclusions containing misfolded proteins. Although the precise molecular mechanisms triggering neurodegeneration remain unclear, endoplasmic reticulum (ER) stress, elevated oxidative and nitrosative stress, and protein misfolding are important features in pathogenesis. Protein disulphide isomerase (PDI) is the prototype of a family of molecular chaperones and foldases upregulated during ER stress that are increasingly implicated in neurodegenerative diseases. PDI catalyzes the rearrangement and formation of disulphide bonds, thus facilitating protein folding, and in neurodegeneration may act to ameliorate the burden of protein misfolding. However, an aberrant posttranslational modification of PDI, S-nitrosylation, inhibits its protective function in these conditions. S-nitrosylation is a redox-mediated modification that regulates protein function by covalent addition of nitric oxide- (NO-) containing groups to cysteine residues. Here, we discuss the evidence for abnormal S-nitrosylation of PDI (SNO-PDI) in neurodegeneration and how this may be linked to another aberrant modification of PDI, S-glutathionylation. Understanding the role of aberrant S-nitrosylation/S-glutathionylation of PDI in the pathogenesis of neurodegenerative diseases may provide insights into novel therapeutic interventions in the future.